This guideline outlines the medical and interventional management of chronic stable angina, emphasizing beta-blockers as first-line therapy and CABG for high-risk coronary anatomy to improve survival.
No takes yet. Share an insight, caveat, or question.
Guides initial therapy and revascularization decisions in stable angina; reinforces evidence-based survival benefits from prior trials.
Stephan D. Fihn (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: